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GUIDELINES FOR AUTHORS
The Journal of Exercise Science & Fitness is published 
twice a year, in June and December, and requires authors 
to be in compliance with the Uniform Requirements for 
Manuscripts Submitted to Biomedical Journals (URMs); 
current URMs are available at http://www.icmje.org.
1. Article Categories
The categories of articles that are published are described 
below.
1.1. Review Articles
These should aim to provide the reader with a balanced 
overview of an important and topical subject in sport and 
exercise sciences and fitness, and should be systematic and 
critical assessments of literature and data sources. They 
should cover aspects of a topic in which scientific consensus 
exists as well as aspects that remain controversial and are 
the subject of ongoing scientific research. All articles and 
data sources reviewed should include information about the 
specific type of study or analysis, population, intervention, 
exposure, and tests or outcomes. All articles or data sources 
should be selected systematically for inclusion in the 
review and critically evaluated.
Typical length: no more than 3000 words, 50–80 
references.
1.2. Original Articles
These may be randomized trials, intervention studies, 
studies of screening and diagnostic tests, laboratory and 
animal studies, cohort studies, cost-effectiveness analyses, 
case-control studies, and surveys with high response rates, 
which represent new and significant contributions to 
exercise science, physical fitness and physical education.
Section headings should be: Abstract, Introduction, 
Methods, Results, Discussion, Acknowledgments (if 
applicable), Conflicts of Interest (if any), and References.
The Introduction should provide a brief background 
to the subject of the paper, explain the importance of the 
study, and state the objective/hypothesis.
The Methods section should describe the study design 
and methods (including the study setting and dates, patients/
participants with inclusion and exclusion criteria, or data 
sources and how these were selected for the study, patient 
samples or animal specimens used, explain the laboratory 
methods followed), and state the statistical procedures 
employed in the research.
The Results section should comprise the study results 
presented in a logical sequence, supplemented by tables 
and/or figures. Take care that the text does not repeat data 
that are presented in tables and/or figures. Only emphasize 
and summarize the essential features of any interventions, 
the main outcome measures, and the main results.
The Discussion section should be used to emphasize the 
new and important aspects of the study, placing the results 
in context with published literature, the implications of the 
findings, and the conclusions that follow from the study 
results.
Typical length: no more than 3000 words, 40–80 
references.
1.3. Case Reports
These are short discussions of a case or case series with 
unique features not previously described that make an 
important teaching point or scientific observation. They 
may describe novel techniques, novel use of equipment, 
or new information on conditions of importance. Section 
headings should be: Abstract, Introduction, Case Report, 
Discussion, Acknowledgments (if applicable), Conflicts of 
Interest (if any), and References.
The Introduction should describe the purpose of the 
report, the significance of the condition, and briefly review 
the relevant literature.
The Case Report should include the general data of 
the case, history, chief complaint, present illness, clinical 
manifestation, methods of diagnosis and treatment, and 
outcome.
The Discussion should compare, analyze and discuss 
the similarities and differences between the reported case 
and similar previously reported cases. The importance or 
specificity of the case should be restated when discussing 
the differential diagnoses. Suggest the prognosis and 
possibility of prevention.
Typical length: no more than 1300 words, 10–30 
references.
1.4. Communications
These are research notes on topics such as test or equipment 
development, profile evaluations, data reanalysis, and 
document verification. Section headings should be: 
Abstract, Introduction, Methods, Results, Discussion, 
Acknowledgments (if applicable), Conflicts of Interest (if 
any), and References.
Typical length: no more than 1000 words, 10–20 
references. The Editors reserve the right to decide what 
constitutes a Communication.
2. Manuscript Submission
Manuscripts should be submitted online through Elsevier’s 
Editorial System (EES). This system can be accessed at 
http://ees.elsevier.com/jesf. This site will guide authors 
stepwise through the submission process. If assistance 
is required, please refer to the tutorials and/or customer 
support that are available on the website, or e-mail the 
Editorial Office at jesf@scsepf.org.
2.1. Important Information
 ● Articles submitted should be in Microsoft Word 
document format and prepared in the simplest form 
possible. We will add in the correct font, font size, 
margins and so on according to the Journal’s style.
 ● You may use automatic page numbering, but do NOT use 
other kinds of automatic formatting such as footnotes, 
headers and footers.
 ● Put text, references, tables and table/figure legends in 
one file.
 ● Figures must be submitted separately as picture files, 
at the correct resolution. The files should be named 
according to the figure number, e.g., “Article1_Fig1”, 
“Article1_Fig2”. Also see Section 6.9.2. below.
2.2. Supporting Documents
The following documents must be included (refer also 
to the Publication Checklist that follows these author 
instructions):
(1) Cover Letter. This must include the name, address, 
telephone and fax numbers, and e-mail address of the 
corresponding author. The letter should state that: (1) all 
authors agree with the content of the article and approve 
of its submission to the Journal; and (2) the experiments 
reported in the article were undertaken in compliance with 
the current laws of the country in which the experiments 
were performed. Please note that authors will be held 
responsible for false statements.
(2) Authorship Statement. Please use the form that is 
provided on the Journal’s website at www.e-jesf.com. ALL 
the authors’ signatures must be included.
(3) Conflicts of Interest Statement. Please use the form that 
is provided on the Journal’s website at www.e-jesf.com. 
Also see Section 3 below.
(4) Copyright Transfer Agreement. Please use the form that 
is provided on the Journal’s website at www.e-jesf.com.
(5) Ethics Statement. Articles covering human or animal 
experiments must be accompanied by a letter of approval 
from the relevant review committee or authorities. Also see 
Section 4 below.
(6) Articles where human subjects can be identified 
in descriptions, photographs or pedigrees must be 
accompanied by a signed statement of informed consent to 
publish (in print and online) the descriptions, photographs 
and pedigrees from each subject who can be identified. 
Also see Section 5 below.
(7) Where material has been reproduced from other copyrighted 
sources, the letter(s) of permission from the copyright holder(s) 
to use the copyrighted sources must be supplied.
3. Disclosure of Conflicts of Interest
All authors are required to sign and submit a financial 
disclosure statement at the time of manuscript submission, 
e.g.,
I certify that all my affiliations with or financial 
involvement in, within the past 5 years and foreseeable 
future, any organization or entity with a financial 
interest in or financial conflict with the subject matter 
or materials discussed in the manuscript are completely 
disclosed (e.g., employment, consultancies, honoraria, 
stock ownership or options, expert testimony, grants or 
patents received or pending, royalties).
Authors who have no relevant financial interests should 
provide a statement indicating that they have no financial 
interests related to the material in the manuscript. Any 
non-financial conflicts of interest should also be explicitly 
declared in your own words.
4. Ethical Approval of Studies and Informed 
Consent
For human or animal experimental investigations, 
appropriate institutional review board or ethics committee 
approval is required, and such approval should be stated 
in the methods section of the manuscript. For those 
investigators who do not have formal ethics review 
committees, the principles outlined in the Declaration of 
Helsinki should be followed (World Medical Association. 
Declaration of Helsinki: ethical principles for medical 
research involving human subjects. Available at: http://
www.wma.net/en/30publications/10policies/b3/index.
html).
For investigations in humans, state explicitly in the 
methods section of the manuscript that informed consent 
was obtained from all participating adults and from parents 
or legal guardians for minors or incapacitated adults, 
together with the manner in which informed consent was 
obtained (ex. oral or written).
For work involving experimental animals, the 
guidelines for their care and use should be in accordance 
with European Commission Directive 86/609/EEC 
for animal experiments (available at http://ec.europa.eu/
environment/chemicals/lab_animals/legislation_en.htm); 
this should be stated in the methods section of the 
manuscript.
5. Identification of Patients in Descriptions, 
Photographs and Pedigrees
A signed statement of informed consent to publish (in 
print and online) patient descriptions, photographs and 
pedigrees should be obtained from all subjects (parents 
or legal guardians for minors) who can be identified 
(including by the subjects themselves) in such written 
descriptions, photographs or pedigrees. Such persons 
should be shown the manuscript before its submission. 
Omitting data or making data less specific to de-identify 
patients is acceptable, but changing any such data is not 
acceptable.
6. Manuscript Preparation
6.1. Basic Criteria
Articles should be written in English (using American 
English spelling) and meet the following basic criteria: the 
material is original, the information is important and of high 
scientific interest, the writing is clear and concise (clinical 
or laboratory jargon is to be avoided), the study methods 
are appropriate, the data are valid, and the conclusions are 
reasonable and supported by the data.
Submitted manuscripts are considered with the 
understanding that they have not been published previously 
in print or electronic format (except in abstract or poster 
form) and are not under consideration in totality or in part 
by another publication or electronic medium.
Text should be typed double-spaced on one side of 
white A4 (297 ¥ 210 mm) paper, with outer margins of 
2.5 cm. A manuscript should include a “first title page”, a 
“second title page”, abstract and keywords, the main text, 
acknowledgments (if any), conflicts of interest statement 
(if any), references, and figures (with legends) and 
tables (with legends) as appropriate. Each section of the 
manuscript should begin on a new page. Pages should be 
numbered consecutively.
The Editor-in-Chief reserves the right to reject 
manuscripts that do not comply with these basic criteria.
6.2. First Title Page
The first title page should contain the following information 
(in order, from the top to bottom of the page):
 ● category of paper
 ● article title
 ● names (spelled out in full)* of all the authors, and the 
institutions with which they are affiliated; indicate all 
affiliations with a superscript lowercase letter after the 
author’s name and in front of the appropriate affiliation
 ● corresponding author details (name, e-mail, mailing 
address, telephone and fax numbers)
*The name of each author should be written with the 
family name last, e.g., Yuen-Lam Cheung. Authorship is 
restricted only to direct participants who have contributed 
significantly to the work. 
6.3. Second Title Page
The second title page should contain the article title only.
6.4. Abstract and Keywords
The third page should contain a concise and factual English 
abstract of no more than 250 words. Abstracts should be 
in one single paragraph with no subheadings. Those 
for Original Articles should include the rationale for the 
study, methods used, most important/significant results, 
and conclusions. Those for Case Reports should include 
the significance and purpose of the case presentation, the 
diagnostic methods of the case, the key data, and brief 
comments and suggestions with regard to the case. Where 
a term/definition will be continually referred to in the 
abstract, it must be written in full when it first appears, 
followed by the subsequent abbreviation in parentheses.
Up to 5 relevant keywords/index terms should be 
provided in alphabetical order for indexing purposes. 
These should not simply be taken from the manuscript title 
but should be representative of the content of the article 
and be characteristic of the terminology used within the 
particular field of the study. They should be taken from 
Index Medicus (Medical Subject Headings, MeSH) or be 
composed by analogy on the same principle.
6.5. Main Text
The text for Original Articles should be organized into the 
following sections: Introduction, Methods, Results and 
Discussion. Sections for Case Reports are: Introduction, 
Case Report, and Discussion. Each section should begin 
on a new page.
6.5.1. Abbreviations
Where a term/definition will be continually referred to, 
it must be written in full when it first appears in the text, 
followed by the subsequent abbreviation in parentheses. 
Thereafter, the abbreviation may be used. An abbreviation 
should not be first defined in any section heading; if an 
abbreviation has previously been defined in the text, then 
the abbreviation may be used in a subsequent section 
heading. Restrict the number of abbreviations to those that 
are absolutely necessary. Author-invented abbreviations 
should be avoided.
6.5.2. Units
Système International (SI) units must be used. Where the 
SI unit is not the conventional unit, then the conventional 
unit should be included in parentheses.
Use the metric system for the expression of length, area, 
mass, and volume. Temperatures are to be given in degrees 
Celsius. Blood pressure values are to be reported in mmHg.
Unit abbreviations should use the power convention, 
e.g., kg·(m2)−1.
6.5.3. Names of drugs, devices and other products
Use the recommended international non-proprietary name 
(rINN) for medicinal substances, unless the specific trade 
name of a drug is directly relevant to the discussion. For 
devices and other products, the generic term should be 
used, unless the specific trade name is directly relevant 
to the discussion. If the trade name is given, then the 
manufacturer name and the city, state and country location 
of the manufacturer must be provided the first time it is 
mentioned in the text, for example, “…SPSS version 11 
was used (SPSS Inc., Chicago, IL, USA).”
6.5.4. Statistical requirements
Statistical analysis is essential for all research papers 
except case reports. Use correct nomenclature of statistical 
methods (e.g., two sample t test, not unpaired t test). 
Descriptive statistics should follow the scales used in 
data description. Inferential statistics are important for 
interpreting results and should be described in detail.
All p values should be expressed to 2 digits to the right of 
the decimal point, unless p < 0.01, in which case the p value 
should be expressed to 3 digits to the right of the decimal point. 
The smallest p value that should be expressed is p < 0.001, 
since additional zeros do not convey useful information; the 
largest p value that should be expressed is p > 0.99.
6.5.5. Personal communications and unpublished data
These sources cannot be included in the references list but 
may be described in the text. The author(s) must give the full 
name and highest academic degree of the person, the date 
of the communication, and indicate whether it was in oral 
or written (letter, fax, e-mail) form. A signed statement of 
permission should be included from each person identified 
as a source of information in a personal communication or 
as a source for unpublished data.
6.5.6. Footnotes
Footnotes should be avoided within the text. Such 
explanatory material can usually be incorporated into the 
text in parentheses.
6.6. Acknowledgments and Conflicts of Interest 
Statement
General acknowledgments for consultations, statistical analysis, 
etc., should be listed concisely at the end of the text, including 
the names of the individuals who were directly involved. 
Consent should be obtained from those individuals before 
their names are listed in this section. All financial and material 
support for the research and work from internal or external 
agencies, including commercial companies, should be clearly 
and completely identified. Ensure that any conflicts of interest 
(financial and/or non-financial) are explicitly declared.
6.7. References
6.7.1. In the main text, tables, figure legends
 ● References should be identified using superscripted 
numbers, and numbered consecutively in order of 
appearance in the text; the numbers should be placed after 
periods and commas and before colons and semicolons.
 ● References cited in tables or figure legends should be 
included in sequence at the point where the table or 
figure is first mentioned in the main text.
 ● Do not cite uncompleted work or work that has not 
yet been accepted for publication (i.e., “unpublished 
observation”, “personal communication”) as references. 
Also see Section 6.5.5. above.
 ● Do not cite abstracts unless they are the only available 
reference to an important concept.
6.7.2. In the references section
 ● References should be limited to those cited in 
the text and listed in numerical order, NOT alphabetical 
order.
 ● References should include, in order, author surnames 
and initials, article title, abbreviated journal name, year, 
volume and inclusive page numbers. The last names and 
initials of all the authors up to 3 should be included, but 
when authors number 4 or more, list the first 3 authors 
only followed by “et al”.
 ● Abbreviations for journal names should conform to 
those used in MEDLINE.
 ● If citing a website, provide the author information, 
article title, website address and the date you accessed 
the information.
 ● Reference to an article that is in press must 
state the journal name and, if possible, the year and 
volume.
Authors are responsible for the accuracy and completeness 
of their references and for correct text citation.
Examples are given below.
Standard journal articles
van Sluijs EM, Kriemler S, McMinn AM. The effect of 
community and family interventions on young people’s 
physical activity levels: a review of reviews and updated 
systematic review. Br J Sports Med. 2011;45:914–922.
Ebben WP, Wurm B, VanderZanden TL, et al. Kinetic 
analysis of several variations of push-ups. J Strength Cond 
Res. 2011;25:2891–2894.
Journal supplement
Kaplan NM. The endothelium as prognostic factor 
and therapeutic target: what criteria should we apply? 
J Cardiovasc Pharmacol. 1998;32(suppl 3):S78–80.
Journal article not in English but with English abstract
Kawai H, Ishikawa T, Moroi J, et al. Elderly patient with 
cerebellar malignant astrocytoma. No Shinkei Geka. 
2008;36:799–805. [In Japanese, English abstract]
Book
Bradley EL. Medical and Surgical Management. 
Philadelphia: Saunders; 1982:72–95.
Book chapter in book with editor and edition
Greaves M, Culligan DJ. Blood and bone marrow. In: 
Underwood JCE, ed. General and Systematic Pathology. 
4th ed. London: Churchill Livingstone; 2004:615–672.
Bulletin
World Health Organization. World Health Report 
2002: Reducing Risk, Promoting Healthy Life. Geneva, 
Switzerland: World Health Organization; 2002.
Company/manufacturer publication/pamphlet
Eastman Kodak Company, Eastman Organic Chemicals. 
Catalog No. 49. Rochester, NY: Eastman Kodak; 1977:2–3.
Electronic publications
Duchin JS. Can preparedness for biological terrorism 
save us from pertussis? Arch Pediatr Adolesc Med. 
2004;158:106–107. Available from: http://archpedi.ama-
assn.org/cgi/content/full/158/2/106. Accessed June 5, 
2004.
Smeeth L, Iliffe S. Community screening for visual 
impairment in the elderly. Cochrane Database Syst Rev. 
2002(2):CD001054. doi:10.1002/14651858.CD1001054.
Items presented at a meeting but not yet published
Durbin D, Kallan M, Elliott M, et al. Risk of injury 
to restrained children from passenger air bags. Paper 
presented at: 46th Annual Meeting of the Association for 
the Advancement for Automotive Medicine; September 
2002; Tempe, AZ.
Greenspan A, Eerdekens M, Mahmoud R. Is there an 
increased rate of cerebrovascular events among dementia 
patients? Poster presented at: 24th Congress of the 
Collegium Internationale Neuro-Psychopharmacologicum 
(CINP); June 20–24, 2004; Paris, France.
Khuri FR, Lee JJ, Lippman SM. Isotretinoin effects on 
head and neck cancer recurrence and second primary 
tumors. In: Proceedings from the American Society of 
Clinical Oncology; May 31–June 3, 2003; Chicago, IL. 
Abstract 359.
Item presented at a meeting and published
Cionni RJ. Color perception in patients with UV- or blue-
light-filtering IOLs. In: Symposium on Cataract, IOL, and 
Refractive Surgery. San Diego, CA: American Society of 
Cataract and Refractive Surgery; 2004. Abstract 337.
Material accepted for publication but not yet published
Carrau RL, Khidr A, Crawley JA, et al. The impact of 
laryngopharyngeal reflux on patient-reported quality of 
life. Laryngoscope. In press.
Ofri D. Incidental Findings: Lessons from my Patients in 
the Art of Medicine. Boston, MA: Beacon Press. In press.
Theses and dissertations
Undeman C. Fully Automatic Segmentation of MRI Brain 
Images Using Probabilistic Diffusion and a Watershed 
Scale–Space Approach [master’s thesis]. Stockholm, 
Sweden: NADA, Royal Institute of Technology; 2001.
Ayers AJ. Retention of Resin Restorations by Means of 
Enamel Etching and by Pins [MSD thesis]. Indianapolis: 
Indiana University; 1971.
Website
American Association of Oral and Maxillofacial Surgeons. 
Wisdom Teeth. AAOMS Web site. http://www.aaoms.org/
wisdom_teeth.php. Accessed November 15, 2009.
6.8. Tables
Tables should be numbered consecutively in the order of 
their citation in the text, have a concise table heading, and 
be comprehensible without reference to the text. Tables 
should be typed double-spaced in as simple a form as 
possible, and data from tables should not be repeated in the 
text or figures. Information requiring explanatory footnotes 
should be denoted using superscripted lowercase letters in 
alphabetical order (a, b, c, etc.). Asterisks (*, **) are used 
only to indicate the probability level of tests of significance. 
Abbreviations used in the table must be defined and placed 
after the footnotes. If you include a block of data or table 
from another source, whether published or unpublished, 
you must acknowledge the original source. 
6.9. Figures
6.9.1. General guidelines
The number of figures should be restricted to the minimum 
necessary to support the textual material. Figures should be 
numbered in the order of their citation in the text (figures 
that are to appear together should be grouped together 
whenever possible). Each figure should have a concise, 
self-sufficient figure legend, and information given in the 
legends should not be repeated in the text. All symbols 
and abbreviations used in the figure should be defined in 
the legend. Patient identification should be obscured. All 
lettering should be in proportion to the drawing, graph or 
photograph. Previously published figures are not usually 
accepted.
Figures must be submitted as separate electronic picture 
files at the correct resolution (see Section 6.9.2. below). 
The files should be named according to the figure number, 
e.g., “Article1_Fig1”, “Article1_Fig2”.
6.9.2. Formats
Regardless of the application used, when your electronic 
artwork is finalized, please “save as” or convert the images 
to one of the following formats (note the resolution 
requirements for line drawings, halftones, and line/halftone 
combinations given below).
 ● EPS: Vector drawings. Embed the font or save the text 
as “graphics”.
 ● TIFF: Color or grayscale photographs (halftones): 
always use a minimum of 300 dpi.
 ● TIFF: Bitmapped line drawings: use a minimum of 1000 
dpi.
 ● TIFF: Combination of bitmapped line/half-tone (color 
or grayscale): a minimum of 600 dpi is required.
 ● DOC, XLS or PPT: If your electronic artwork is created 
in any of these Microsoft Office applications, please 
supply “as is”.
Please do not:
 ● Supply files that are optimized for screen use (like GIF, 
BMP, PICT, WPG), as the resolution is too low;
 ● Supply files that are lower in resolution than the 
requirements listed above;
 ● Submit graphics that are disproportionately large for the 
content.
A detailed guide on electronic artwork is available at http://
www.elsevier.com/artworkinstructions.
7. The Editorial and Peer Review Process
As a general rule, the receipt of a manuscript will be 
acknowledged within 1 week of submission, and authors 
will be provided with a manuscript reference number for 
future correspondence. If such an acknowledgment is not 
received in a reasonable period of time, the author should 
contact the Editorial Office.
Submissions are reviewed by the Editorial Office to 
ensure that it contains all parts. The Editorial Office will 
not accept a submission if the author has not supplied all 
the material and documents as outlined in these author 
instructions.
Manuscripts are then forwarded to the Editor-in-Chief, 
who makes an initial assessment of it. If the manuscript does 
not appear to be of sufficient merit or is not appropriate for 
the Journal, then the manuscript will be rejected without 
review.
Manuscripts that appear meritorious and appropriate 
for the Journal are subjected to double-blind review and 
seen by at least two Editorial Board members or expert 
consultants assigned by the Editor-in-Chief. Authors may 
be required to answer open questions or to supply missing 
information. Authors will usually be notified within 
6 weeks of whether the submitted article is accepted 
for publication, rejected, or subject to revision before 
acceptance. However, do note that delays are sometimes 
unavoidable.
8. Preparation for Publication
Once a manuscript has been accepted for publication, the 
authors should submit the final version of their manuscript 
(and final versions of all tables/figures as applicable).
Accepted manuscripts are copyedited according to the 
Journal’s style and PDF page proofs are e-mailed by the 
Publisher to the corresponding author for final approval. 
Authors are responsible for all statements made in their work, 
including changes made by the copy editor.
9. Reprints
Authors receive 20 stapled offprints of their articles free of 
charge, which are sent to the corresponding author.
Professional reprints (which include a cover page for the 
article) may be ordered from the Publisher at prices based on 
the cost of production. Reprint order and credit card payment 
forms can be downloaded from the Journal’s website at 
www.e-jesf.com.
10. Copyright
Published manuscripts in the Journal of Exercise Science 
& Fitness become the permanent property of The Society 
of Chinese Scholars on Exercise Physiology and Fitness. 
All articles published in the Journal are protected by 
copyright, which covers the exclusive rights to reproduce 
and distribute the article, as well as translation rights. No 
part of this publication may be reproduced, stored in any 
retrieval system, or transmitted in any form or by any 
means, electronic, mechanical, by photocopying, recording, 
or otherwise, without prior written permission from The 
Society of Chinese Scholars on Exercise Physiology and 
Fitness.
